You can find the latest information regarding Thalidomide here, together with infographics and other useful resources to download.


Grünenthal supports the public ambitions of the Contergan Foundation to facilitate an early payout of the remaining foundation capital to people affected by thalidomide. The exchange between Grünenthal and the affected parties made it clear that a larger, early payout now would make a greater contribution to improving their living situation than the annual special payments made to date.


50 years ago today, the Aachen Regional Court terminated the Thalidomide proceedings against nine Grünenthal senior employees. The criminal trial is still considered one of the most complex and costly proceedings in German legal history. The legal and medical questions concerning the Thalidomide tragedy were complex and difficult to answer.


The German federal parliament adopted an amendment to the Contergan Foundation Act on 19 June 2020, whereby benefits to thalidomide victims, once granted, cannot be revoked. This includes the thalidomide pension, which is paid by the Contergan Foundation. Only in special cases, such as deliberate deception, is it possible to withdraw benefits.


The pensions paid by the Contergan Foundation to people affected by thalidomide in Germany and abroad will be increased by 3.22 percent as of July 1, 2018.


After more than 60 years, researchers at the renowned Dana-Farber Cancer Institute in Boston have succeeded in identifying the causes of thalidomide-induced congenital malformations.

Downloadable material

Please make use of the following material. However, we kindly ask that you reference “Grünenthal GmbH” as the source.

Press kit: The Thalidomide trial in Germany – 50 years on

Press kit:
The Thalidomide trial in Germany – 50 years on

... Download
Infographic Financial support for people affected by Thalidomide

Financial support for people affected by Thalidomide

... Download